Literature DB >> 9688415

Only hydrosalpinges visible on ultrasound are associated with reduced implantation and pregnancy rates after in-vitro fertilization.

W de Wit1, C J Gowrising, D J Kuik, J W Lens, R Schats.   

Abstract

A retrospective analysis of clinical and laboratory data was made of all in-vitro fertilization (IVF) patients with tubal pathology who had their first ever embryo transfer cycle between January 1st, 1992 and September 1st, 1996. The aim of the study was to determine the effect of the presence of a hydrosalpinx, whether or not visible by ultrasound, on pregnancy, multiple pregnancy and implantation rates in our patient population. The IVF success rate was also analysed by calculating cumulative ongoing pregnancy rates of the same patient group using the lifetime table approach. In the presence of an ultrasound-visible hydrosalpinx, rates of pregnancy and multiple pregnancy appeared reduced, but the differences were not significant. The rates of implantation, clinical implantation and ongoing implantation were significantly lower in the presence of an ultrasound-visible hydrosalpinx (odds ratios 0.33-0.46, C.I. 0.21-0.96). The cumulative chance of achieving an ongoing pregnancy after one or more IVF cycles was significantly reduced in the presence of an ultrasound-visible hydrosalpinx (relative hazard 0.36, C.I. 0.22-0.59). In the presence of a hydrosalpinx not visible by ultrasound the IVF outcome was not reduced. This retrospective study confirms that patients with hydrosalpinges have an impaired IVF outcome. Unique to this study and previously unobserved is the finding that there is a subgroup of patients with hydrosalpinges, those with ultrasound-visible hydrosalpinges, which is exclusively responsible for this impaired outcome.

Entities:  

Mesh:

Year:  1998        PMID: 9688415     DOI: 10.1093/humrep/13.6.1696

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  6 in total

1.  How members of the Society for Reproductive Endocrinology and Infertility and Society of Reproductive Surgeons evaluate, define, and manage hydrosalpinges.

Authors:  Kenan Omurtag; Natalia M Grindler; Kimberly A Roehl; Gordon Wright Bates; Angeline N Beltsos; Randall R Odem; Emily S Jungheim
Journal:  Fertil Steril       Date:  2012-03-09       Impact factor: 7.329

2.  Salpingectomy for repeated embryo nonimplantation after in vitro fertilization in patients with severe tubal factor infertility.

Authors:  H Dechaud; T Anahory; N Aligier; F Arnal; H Humeau; B Hedon
Journal:  J Assist Reprod Genet       Date:  2000-04       Impact factor: 3.412

3.  Effect of endometrial cavity fluid on clinical pregnancy rate in tubal embryo transfer (TET).

Authors:  Robert Kuo-Kuang Lee; San-Li Yu; Yu-Fen Chih; Yi-Chun Tsai; Ming-Huei Lin; Yuh-Ming Hwu; Wen-Yu Huang; Jin-Tsung Su
Journal:  J Assist Reprod Genet       Date:  2006-05       Impact factor: 3.412

4.  State-mandated insurance coverage is associated with the approach to hydrosalpinges before IVF.

Authors:  Kenan Omurtag; Natalia M Grindler; Kimberly A Roehl; G Wright Bates; Angeline N Beltsos; Randall R Odem; Emily S Jungheim
Journal:  Reprod Biomed Online       Date:  2014-03-24       Impact factor: 3.828

5.  Hydrosalpinx functional surgery or salpingectomy? The importance of hydrosalpinx fluid in assisted reproductive technologies.

Authors:  Mandakini Parihar; Aparna Mirge; Reshma Hasabe
Journal:  J Gynecol Endosc Surg       Date:  2009-01

6.  Laparoscopic surgery: Any role in patients with unexplained infertility and failed in vitro fertilization cycles?

Authors:  Xiaoming Yu; He Cai; Jing Guan; Xingbang Zheng; Hongjing Han
Journal:  Medicine (Baltimore)       Date:  2019-03       Impact factor: 1.889

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.